Joel Lewis, President and CEO at GALECTIN THERAPEUTICS INC (GALT), sold 38,143 shares at $6.04 ($231K) on 2025-11-17, disclosed to the SEC on 2025-11-19.
Scheduled sale ($231k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.04 | 15,680 | $95K | 41.0% |
| 2 | $6.04 | 15,680 | $95K | 41.0% |
| 3 | $6.15 | 6,783 | $42K | 18.0% |
| Total | $6.06 avg | 38,143 | $231K | 100% |
| Filing → |
| GALT | SELL | 2025-11-12 | $11K | — | Filing → |
| GALT | SELL | 2025-11-07 | $1K | — | Filing → |
| GALT | SELL | 2025-11-05 | $183K | — | Filing → |